Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation And Successful Treatment With Rituximab

After kidney transplantation, approximately 40% of patients with membranous glomerulonephritis experience recurrence, most commonly during the first year. We present 2 patients with recurrent membranous glomerulonephritis after kidney transplantation that were successfully treated with rituximab.